 | Up a level |
Krempaska, Kristina; Barnowski, Sandra; Gavini, Jacopo; Hobi, Nina; Ebener, Simone; Simillion, Cedric; Stokes, Andrea; Schliep, Ronja; Knudsen, Lars; Geiser, Thomas K.; Funke-Chambour, Manuela (2020). Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls. Respiratory research, 21(1), p. 29. BioMed Central 10.1186/s12931-020-1304-7
Krempaska, Kristina; Barnowski, Sandra; Gavini, Jacopo; Hobi, Nina; Ebener, Simone; Simillion, Cedric; Stokes, Andrea; Schliep, Ronja; Knudsen, Lars; Geiser, Thomas K.; Funke-Chambour, Manuela (2020). αAzithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls. Respiratory research, 21(1), p. 25. BioMed Central 10.1186/s12931-020-1275-8
Ebener, Simone; Barnowski, Sandra; Wotzkow Alvarez, Carlos; Marti, Thomas; Lopez-Rodriguez, Elena; Crestani, Bruno; Blank, Fabian; Schmid, Ralph; Geiser, Thomas; Funke, Manuela (2017). Toll-like receptor 4 activation attenuates profibrotic response in control lung fibroblasts but not in fibroblasts from patients with IPF. American journal of physiology - lung cellular and molecular physiology, 312(1), L42-L55. American Physiological Society 10.1152/ajplung.00119.2016
